1. Home
  2. ABR vs NUVB Comparison

ABR vs NUVB Comparison

Compare ABR & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.74

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
NUVB
Founded
2003
2018
Country
United States
United States
Employees
653
298
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ABR
NUVB
Price
$5.74
$4.76
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$9.90
$11.38
AVG Volume (30 Days)
5.6M
4.2M
Earning Date
05-08-2026
05-04-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$203.82
Revenue Next Year
N/A
$58.18
P/E Ratio
$9.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.40
$1.57
52 Week High
$12.58
$9.75

Technical Indicators

Market Signals
Indicator
ABR
NUVB
Relative Strength Index (RSI) 33.40 52.73
Support Level N/A $4.07
Resistance Level $8.08 $5.23
Average True Range (ATR) 0.34 0.25
MACD -0.04 0.02
Stochastic Oscillator 18.82 71.35

Price Performance

Historical Comparison
ABR
NUVB

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: